We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$21.2B
AUM Growth
+$1.07B
(+5.3%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
1.06%
Top 10 Holdings %
Top 10 Hldgs %
9.44%
Holding
1,639
New
311
Increased
467
Reduced
550
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$211M |
| 2 |
AbbVie
ABBV
|
+$176M |
| 3 |
Apple
AAPL
|
+$170M |
| 4 |
Nike
NKE
|
+$161M |
| 5 |
Coca-Cola
KO
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$221M |
| 2 |
Medtronic
MDT
|
+$163M |
| 3 |
UnitedHealth
UNH
|
+$148M |
| 4 |
Johnson & Johnson
JNJ
|
+$133M |
| 5 |
Pfizer
PFE
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Consumer Discretionary | 14.98% |
| 3 | Healthcare | 13.91% |
| 4 | Financials | 10.93% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Lindsay Corp
LNN
$1.17B
| $951K | ﹤0.01% |
7,965
+273
| +4% | +$33.9K |
|
1127
Buckle
BKE
$2.31B
| $949K | ﹤0.01% |
27,431
-15,044
| -35% | -$505K |
|
1128
Schneider National
SNDR
$6.37B
| $945K | ﹤0.01% |
32,891
-12,392
| -27% | -$330K |
|
1129
Warrior Met Coal
HCC
$4.98B
| $944K | ﹤0.01% |
+24,247
| New | +$878K |
|
1130
PagerDuty
PD
$932M
| $944K | ﹤0.01% |
+42,009
| New | +$1.17M |
|
1131
Kontoor Brands
KTB
$4.65B
| $938K | ﹤0.01% |
22,287
-41,605
| -65% | -$1.79M |
|
1132
Beam Therapeutics
BEAM
$2.74B
| $931K | ﹤0.01% |
29,161
-29,655
| -50% | -$962K |
|
1133
Sensient Technologies
SXT
$5.53B
| $926K | ﹤0.01% |
13,024
-692
| -5% | -$51.4K |
|
1134
Supernus Pharmaceuticals
SUPN
$2.74B
| $925K | ﹤0.01% |
+30,759
| New | +$1.08M |
|
1135
NMI Holdings
NMIH
$3.42B
| $923K | ﹤0.01% |
35,748
-46,176
| -56% | -$1.12M |
|
1136
Gerdau
GGB
$9.42B
| $915K | ﹤0.01% |
210,388
-1,042,960
| -83% | -$4.36M |
|
1137
Hope Bancorp
HOPE
$1.85B
| $913K | ﹤0.01% |
108,463
-16,297
| -13% | -$142K |
|
1138
Tootsie Roll Industries
TR
$3.02B
| $907K | ﹤0.01% |
+27,983
| New | +$1.02M |
|
1139
Jazz Pharmaceuticals
JAZZ
$16B
| $906K | ﹤0.01% |
+7,307
| New | +$983K |
|
1140
LendingTree
TREE
$461M
| $902K | ﹤0.01% |
40,816
-81,529
| -67% | -$1.74M |
|
|
VTLE
1141
DELISTED
Vital Energy
VTLE
| $898K | ﹤0.01% |
19,896
-69,413
| -78% | -$3.14M |
|
1142
Plexus
PLXS
$7.04B
| $895K | ﹤0.01% |
9,112
+4,596
| +102% | +$421K |
|
|
EB
1143
DELISTED
Eventbrite
EB
| $884K | ﹤0.01% |
+92,574
| New | +$728K |
|
|
PRMW
1144
DELISTED
Primo Water Corporation
PRMW
| $883K | ﹤0.01% |
+70,439
| New | +$986K |
|
1145
Autohome
ATHM
$2.6B
| $883K | ﹤0.01% |
30,280
+3,294
| +12% | +$98.3K |
|
1146
Ultragenyx Pharmaceutical
RARE
$2.6B
| $878K | ﹤0.01% |
19,027
-101,447
| -84% | -$4.71M |
|
1147
Deutsche Bank
DB
$72.1B
| $861K | ﹤0.01% |
81,769
-30,239
| -27% | -$319K |
|
1148
Independent Bank
INDB
$4.05B
| $861K | ﹤0.01% |
19,333
+6,302
| +48% | +$327K |
|
1149
Omega Healthcare
OHI
$13.9B
| $860K | ﹤0.01% |
+28,038
| New | +$810K |
|
|
WCC
1150
WESCO International
WCC
$17.5B
| $852K | ﹤0.01% |
4,759
-28,665
| -86% | -$4.18M |
|
Similar funds
JG
OAG
WP
Voloridge Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, Voloridge Investment Management held 1,639 positions worth $21.2B, up 5.3% from $20.1B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Voloridge Investment Management's Q2 2023 filing shows 311 new, 467 increased, 550 reduced and 311 closed positions. Its largest new stake was Berkshire Hathaway Class B: 646,010 shares worth $220M. The largest sale was Accenture, an estimated $221M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Voloridge Investment Management's largest Q2 2023 buy was Berkshire Hathaway Class B: 646,010 shares worth $220M.
- Voloridge Investment Management added most to Coca-Cola in Q2 2023, an estimated $141M increase.
- Voloridge Investment Management's biggest Q2 2023 reduction was Medtronic, cutting an estimated $163M.
- Voloridge Investment Management fully exited Accenture in Q2 2023, selling an estimated $221M.
- Voloridge Investment Management's ten largest holdings make up 9.4% of its $21.2B portfolio in Q2 2023.
- Voloridge Investment Management opened 311 new positions and closed 311 in Q2 2023.
- Voloridge Investment Management's portfolio value rose 5.3% quarter-over-quarter to $21.2B.
Based on Voloridge Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.